Immune Checkpoints HLA-E:CD94-NKG2A and HLA-C:KIR2DL1 Complementarily Shield Circulating Tumor Cells from NK-mediated Immune Surveillance

Overview

Journal Cell Discov

Date 2024 Feb 9

PMID 38336855

Authors

Xiaowei Liu

Fengli Zuo

Jinen Song

Leyi Tang

Xueyan Wang

Xinyu Liu

Hao Zhang

Zhankun Yang

Jing Jing

Xuelei Ma

Hubing Shi

Affiliations

Soon will be listed here.

Citing Articles

Differential Role of NKG2A/HLA-E Interaction in the Outcomes of Bladder Cancer Patients Treated with BCG or Other Therapies.

Ruiz-Lorente I, Gimeno L, Lopez-Abad A, Lopez Cubillana P, Fernandez Aparicio T, Asensio Egea L Biomedicines. 2025; 13(1).

PMID: 39857739 PMC: 11760850. DOI: 10.3390/biomedicines13010156.

LLT1 overexpression renders allogeneic-NK resistance and facilitates the generation of enhanced universal CAR-T cells.

Zhu S, Zuo S, Li C, You X, Jiang E, Feng X J Exp Clin Cancer Res. 2025; 44(1):25.

PMID: 39856752 PMC: 11763111. DOI: 10.1186/s13046-025-03273-2.

Targeting HLA-E in Lung Cancer: The Therapeutic Potential of IRF5-Engineered M1-Macrophage-Derived Exosomes.

Feng X, Lai X, Zhou M, Bie J, Li T, Wang D Clin Respir J. 2024; 18(12):e70035.

PMID: 39623605 PMC: 11611755. DOI: 10.1111/crj.70035.

Whole Exome Sequencing of Intracranial Epidermoid Cysts Reveals Immune-Associated Mechanistic and Potential Targets.

Kondaboina S, Parrish O, Parada C, Ferreira Jr M Cancers (Basel). 2024; 16(20).

PMID: 39456581 PMC: 11506683. DOI: 10.3390/cancers16203487.

The complexity of immune evasion mechanisms throughout the metastatic cascade.

Haynes N, Chadwick T, Parker B Nat Immunol. 2024; 25(10):1793-1808.

PMID: 39285252 DOI: 10.1038/s41590-024-01960-4.

References

Liu X, Song J, Zhang H, Liu X, Zuo F, Zhao Y . Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance. Cancer Cell. 2023; 41(2):272-287.e9. DOI: 10.1016/j.ccell.2023.01.001. View

Welch D, Hurst D . Defining the Hallmarks of Metastasis. Cancer Res. 2019; 79(12):3011-3027. PMC: 6571042. DOI: 10.1158/0008-5472.CAN-19-0458. View

Liu X, Song J, Liu X, Zhang H, Wang X, Li Y . Protocol for identifying immune checkpoint on circulating tumor cells of human pancreatic ductal adenocarcinoma by single-cell RNA sequencing. STAR Protoc. 2023; 4(3):102539. PMC: 10491853. DOI: 10.1016/j.xpro.2023.102539. View

Szczerba B, Castro-Giner F, Vetter M, Krol I, Gkountela S, Landin J . Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature. 2019; 566(7745):553-557. DOI: 10.1038/s41586-019-0915-y. View

Fauriat C, Andersson S, Bjorklund A, Carlsten M, Schaffer M, Bjorkstrom N . Estimation of the size of the alloreactive NK cell repertoire: studies in individuals homozygous for the group A KIR haplotype. J Immunol. 2008; 181(9):6010-9. DOI: 10.4049/jimmunol.181.9.6010. View

Mohme M, Riethdorf S, Pantel K . Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape. Nat Rev Clin Oncol. 2016; 14(3):155-167. DOI: 10.1038/nrclinonc.2016.144. View

Uhrberg M, Valiante N, Shum B, Shilling H, Corliss B, Tyan D . Human diversity in killer cell inhibitory receptor genes. Immunity. 1998; 7(6):753-63. DOI: 10.1016/s1074-7613(00)80394-5. View

Crinier A, Dumas P, Escaliere B, Piperoglou C, Gil L, Villacreces A . Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia. Cell Mol Immunol. 2020; 18(5):1290-1304. PMC: 8093261. DOI: 10.1038/s41423-020-00574-8. View

Bi J, Wang X . Molecular Regulation of NK Cell Maturation. Front Immunol. 2020; 11:1945. PMC: 7431948. DOI: 10.3389/fimmu.2020.01945. View

10.

Plaks V, Koopman C, Werb Z . Cancer. Circulating tumor cells. Science. 2013; 341(6151):1186-8. PMC: 3842225. DOI: 10.1126/science.1235226. View

11.

Myers J, Miller J . Exploring the NK cell platform for cancer immunotherapy. Nat Rev Clin Oncol. 2020; 18(2):85-100. PMC: 8316981. DOI: 10.1038/s41571-020-0426-7. View

12.

Lambert A, Pattabiraman D, Weinberg R . Emerging Biological Principles of Metastasis. Cell. 2017; 168(4):670-691. PMC: 5308465. DOI: 10.1016/j.cell.2016.11.037. View

13.

Carrette F, Vivier E . NKG2A blocks the anti-metastatic functions of natural killer cells. Cancer Cell. 2023; 41(2):232-234. DOI: 10.1016/j.ccell.2023.01.008. View

14.

Hazini A, Fisher K, Seymour L . Deregulation of HLA-I in cancer and its central importance for immunotherapy. J Immunother Cancer. 2021; 9(8). PMC: 8344275. DOI: 10.1136/jitc-2021-002899. View

15.

Sun Y, Wu L, Liu S, Jiang M, Hu B, Zhou K . Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma. Nat Commun. 2021; 12(1):4091. PMC: 8253833. DOI: 10.1038/s41467-021-24386-0. View